Acrobiosystems Co., Ltd. (SZSE: 301080) has released its semi-annual report for fiscal year 2026, revealing a solid financial performance for the period.
The company achieved operating revenue of RMB 500 million during the reporting period, marking a substantial increase of 28.97% year-over-year.
Net profit attributable to shareholders of the listed company reached RMB 98.36 million, up 17.36% compared to the same period last year. After adjusting for non-recurring gains and losses, net profit attributable to shareholders stood at RMB 89.83 million, reflecting a more modest growth rate of 6.78%.
Basic earnings per share for the period were reported at RMB 0.5883.
Comments